09:34 AM EDT, 05/13/2024 (MT Newswires) -- AbbVie ( ABBV ) and Gilgamesh Pharmaceuticals said Monday that they have entered into an option-to-license agreement to develop neuroplastogens to treat psychiatric disorders. Development and commercialization activities will be led by AbbVie ( ABBV ) upon exercise of the option, according to the companies. Gilgamesh will get $65 million in upfront payment...

09:31 AM EDT, 05/13/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) said Monday that it has signed an accelerated share repurchase agreement with investment bank Jefferies to buy back $35 million of its common stock. Collegium said it will execute the deal as part of a $150 million share repurchase program the board authorized in January. Following the completion...

09:31 AM EDT, 05/13/2024 (MT Newswires) -- Permian Resources ( PR ) said Monday that certain shareholders had launched a public offering of about 51.8 million of its Class A shares. The company said the sellers include certain affiliates of EnCap Investments, NGP Energy Capital Management, Pearl Energy Investments, Riverstone Investment Group, and a member of Permian's board. The oil...

09:32 AM EDT, 05/13/2024 (MT Newswires) -- (Updates with additional information) Blackstone (BX) said Monday its private equity funds and vehicles have entered a definitive agreement with the management of Japanese pharmaceutical services company I'rom Group to take it private. The asset management firm will offer to acquire I'rom shares at 2,800 yen ($17.96) per share -- about a 50%...